Transitioning From Cyclosporine to Alefacept in Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

May 31, 2007

Conditions
Psoriasis
Interventions
DRUG

Transitioning patients from cyclosporine to alefacept

Trial Locations (1)

08903

UMDNJ Clinical Research Center, New Brunswick

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

University of Medicine and Dentistry of New Jersey

OTHER